The advertisement provides important safety information regarding the medication Eliquis, highlighting risks associated with its premature discontinuation and the potential for serious side effects.
Creative Information
| CID: | 096ceb2b-52e5-47d8-a539-2271bbf20303 |
| CRID: | 89_219381 |
| Domain: | eliquis.com |
| Seat: | DInt |
| Size: | 728x90 |
| Bid: | $1.50 |
| Timestamp: | 11/26/2025, 4:48:30 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/26/2025, 6:10:42 PM | 5.68s | |
| adomain_analysis | success | 11/26/2025, 6:10:47 PM | 4.41s | |
| adomain_capture | success | 11/26/2025, 6:10:42 PM | 0.18s | |
| ad_render | success | 11/26/2025, 6:10:36 PM | 18.34s | |
| brand_mapping | success | 11/26/2025, 4:48:31 PM | 0.15s | |
Analysis Results
Ad Format: banner
Brands: Eliquis
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1582.87 KB | ||||||||||||||||||||||
| Render Time: | 9.37 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1582.87 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Raw Ad Markup
<span id='deepintent_wrapper_b9f11af5-165d-486e-a70a-bdaa8b380e8b' onclick=DeepIntentExecuteClicks('')><div style='display:inline-block;position:relative;height:90px'><script type='text/javascript'>document.addEventListener('DOMContentLoaded',function(){setTimeout(function(){new Image().src='https://useast-beacon.deepintent.com/vi?impid=31f929e8-7b08-8289-2c47-a40c4863aa2d&spanlen='+ (document.getElementById('deepintent_wrapper_span_3-a18c-24d3-05b0-6a133889db2a').innerHTML.length) + '&spanelemcnt=' + (document.getElementById('deepintent_wrapper_span_3-a18c-24d3-05b0-6a133889db2a').getElementsByTagName('*').length);},3000)});</script><span id='deepintent_wrapper_span_3-a18c-24d3-05b0-6a133889db2a'><ins class='dcmads' style='display:inline-block;width:728px;height:90px' data-dcm-placement='N2123577.3219362APEXDEALS/B32886535.422562141' data-dcm-rendering-mode='script' data-dcm-landing-page-escapes='2' data-dcm-click-tracker='https://useast-beacon.deepintent.com/click/31f929e8-7b08-8289-2c47-a40c4863aa2d?ts=1764118590482&wp=1.5&loc=1&r=' data-dcm-https-only data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=${GDPR}' data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-resettable-device-id='' data-dcm-app-id='' data-dcm-param-dvs1='1' data-dcm-param-dvs2='${SOURCE_URL_ENC}' data-dcm-param-dvs3='214770' data-dcm-param-dvs4='31f929e8-7b08-8289-2c47-a40c4863aa2d' data-dcm-param-dvs5='1' data-dcm-param-dvs6='103' data-dcm-param-dvs7='${BUNDLE_ID}' data-dcm-param-dvs8='219381' data-dcm-param-dvs9='${INSERTION_ORDER_ID}' data-dcm-param-dvs10='8482' data-dcm-param-dvs11='${UNIVERSAL_SITE_ID}' data-dcm-param-dvs12='${EXCHANGE_ID}' data-dcm-param-dvs13='1404354615' data-dcm-param-dvs14='1404354615' data-dcm-param-dvs15='${INVENTORY_SOURCE_EXTERNAL_ID}'> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins></span><script src="https://cdn.doubleverify.com/dvtp_src.js?ctx=20515845&cmp=DV973873&sid=deepintent&plc=deepintent_im_disp_js&adsrv=0&advid=3891363&ppid=118&dvtagver=6.1.src&aufilter1=IM&autt=1&auevent=31f929e8-7b08-8289-2c47-a40c4863aa2d&aubndl=&pltfrm=10035&auip=32.220.208.242&DVPX_PP_AUCTION_UA=Mozilla%2F5.0+%28Linux%3B+Android+10%3B+K%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F142.0.0.0+Safari%2F537.36&turl=https%3A%2F%2Fwww.slashgear.com%2F2027958%2Fworst-chainsaw-models-consumer-reports%2F" type="text/javascript"></script><div id='aeopt' style='position:absolute;z-index:9010;background-color:#CCCCCCCC;top:0;right:0;border-radius:0 0 0 5px;'><div id='aeopti' style='display:block;'><a href='https://www.deepintent.com/adchoices?payload=di_cfc07fe21d814e96b36cc%2C1%2C6e61ad7929af5a3ab5326b1d48f21c5d%2C3%2C32.220.208.242%2C4%2Caa433022-9f2a-40b5-be68-e1e25126a3b5%2C135%2Chc_aabd2b6e738e5daed3309326aa4d49d7%2C7%2Cfc4f049a520aef809ebd1d417d891dd8b7ad0f1f%2C8%2C25376618093dad0463e78224c32e44abfc1c20de2215e9fd838ade1b5c67d0b5%2C9%2CDBB9A3B25E223CC265F9883242D76CB4F0F4E878AE88E00B6576DE17A298FCBF%2C10%2CU3ZPOtFnzcO%2FT2n4AE03k6a6GyT%2BCb1NJiInK647oKs%3D%2C11%2CLV5F00KUSAO2YRD2WTVB6LONIZNJI43M47SQ%2C12%2CEDI_fzrfWB4Pjcd9BdHwVIjExgutL%252F%252FcoalUvlxm6rZbI%252B9KzlKOiNY0G6Mdk9BUvj1r%2C14%2CEH_KJygTbLSKrqAW0mlvm9Pd5AMEMRqXr%252B5T0yjmEsrZEtA%252BPBvdF%252BMD6Pdl1MazGt6%2C15%2CXY136423MXnvG_7c9jHA2dDiIJwDkxAbdc5giiHl2ClPpm_dE%2C112%2CU081173929%2C114%2CTH_86817140%2C121%2Caf6f37f74f7b4963e27505ed7298bff1' target='_blank' style='display:block;padding:1px 2px 1px 5px;'><img src='https://cdn.deepintent.com/adchoices/di-adchoices.png' alt='AdChoices' border='0' width='13' height='13' style='display:block;'></a></div></div></div></span><script type='text/javascript'>window.DeepIntentExecuteClicks=window.DeepIntentExecuteClicks||function(e){if(e)for(var n=e.split(','),t=0;t<n.length;t++)if(n[t])(new Image).src=n[t]};</script><noscript><img src='https://useast-beacon.deepintent.com/impression/31f929e8-7b08-8289-2c47-a40c4863aa2d?ts=1764118590482&wp=1.5' height='0px' width='0px' style='display:none' referrerpolicy='no-referrer-when-downgrade'></noscript><script type="text/javascript">(function(){var r;try{r=window.location.ancestorOrigins[window.location.ancestorOrigins.length-1];}catch(e){}new Image().src='https://useast-beacon.deepintent.com/impression/31f929e8-7b08-8289-2c47-a40c4863aa2d?ts=1764118590482&wp=1.5'+((typeof r==='string')?'&rf='+r:'');})();</script><iframe src='https://cdn.deepintent.com/syncpixel.html?_di_cfg=a' width='0' height='0' style='display:none;'></iframe>Creatives
